Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Social Behavior
1 trial -
Oxytocin
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
POHIM-RT
Samsung Bioepis NL B.V.
Cervix Cancer
1 trial -
PRDR
Beam Therapeutics
Glioma
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel Oral Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Small-Cell Lung Cancer
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancers
1 trial -
Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar
The University of Hong Kong
Recurrent Ovarian Carcinoma
1 trial -
Paroxetine
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
Peginterferon Ξ±-2b injection
The First People's Hospital of Lianyungang
Condylomata Acuminata
1 trial -
Percutaneous Transluminal Angioplasty (PTA)
Blackmores Limited
Peripheral Artery Disease
1 trial -
Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter
Blackmores Limited
Peripheral Artery Disease
1 trial -
Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand
The First People's Hospital of Lianyungang
Malignant Obstructive Jaundice
1 trial -
Personalized Functional Profiling
Universal Integrated
Oncology
1 trial -
Phase 1 Wonderlab Product
Chongqing Precision Biotech Co., Ltd
Diabetes
1 trial -
Photo-responsive nanozyme
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Physiotherapy
Chinese University of Hong Kong
Knee Arthropathy
1 trial -
Pioglitazone
Takeda
Uric Acid Kidney Stone Disease
1 trial -
Pioglitazone
Takeda
HIV Infections
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
2 trials -
Placebo
Hospital Authority, Hong Kong
Hypertension in Pregnancy
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorder
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources